David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
CALL
Dollar General
DG
$26.8B
| $3.9M | 0.01% |
48,100
| – | – |
|
1527
Pan American Silver
PAAS
$22B
| $3.9M | 0.01% |
228,584
+162,598
| +246% | +$2.8M |
|
1528
Kaiser Aluminum
KALU
$2.54B
| $3.89M | 0.01% |
37,720
-25,502
| -40% | -$2.46M |
|
|
GLDD
1529
DELISTED
Great Lakes Dredge & Dock
GLDD
| $3.88M | 0.01% |
800,456
+28,004
| +4% | +$117K |
|
1530
Citi Trends
CTRN
$585M
| $3.88M | 0.01% |
195,336
+6,554
| +3% | +$130K |
|
1531
Heron Therapeutics
HRTX
$59.4M
| $3.88M | 0.01% |
240,175
+182,875
| +319% | +$2.87M |
|
1532
Prospect Capital
PSEC
$1.19B
| $3.88M | 0.01% |
577,122
-21,525
| -4% | -$161K |
|
1533
Manchester United
MANU
$4.09B
| $3.88M | 0.01% |
215,254
-2,780
| -1% | -$46.9K |
|
|
CERN
1534
DELISTED
Cerner Corp
CERN
| $3.88M | 0.01% |
54,331
-722,060
| -93% | -$47.9M |
|
|
CCMP
1535
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $3.87M | 0.01% |
48,442
+29,339
| +154% | +$2.16M |
|
|
ATVI
1536
PUT
DELISTED
Activision Blizzard
ATVI
| $3.87M | 0.01% |
+60,000
| New | +$3.74M |
|
1537
CALL
Churchill Downs
CHDN
$6.12B
| $3.86M | 0.01% |
112,200
+43,800
| +64% | +$1.4M |
|
|
EXAS
1538
PUT
DELISTED
Exact Sciences
EXAS
| $3.85M | 0.01% |
81,800
+2,800
| +4% | +$113K |
|
1539
Sabra Healthcare REIT
SBRA
$5.34B
| $3.85M | 0.01% |
175,473
+153,638
| +704% | +$3.47M |
|
1540
PUT
Eli Lilly
LLY
$1.06T
| $3.85M | 0.01% |
45,000
| – | – |
|
1541
Xylem
XYL
$26.6B
| $3.85M | 0.01% |
61,450
-88,772
| -59% | -$5.31M |
|
1542
Rigel Pharmaceuticals
RIGL
$859M
| $3.84M | 0.01% |
151,120
+15,591
| +12% | +$379K |
|
1543
M/I Homes
MHO
$3.91B
| $3.83M | 0.01% |
143,389
+1,404
| +1% | +$36.4K |
|
1544
Aecom
ACM
$8.29B
| $3.82M | 0.01% |
+103,869
| New | +$3.41M |
|
|
CYOU
1545
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $3.81M | 0.01% |
96,261
-20,946
| -18% | -$844K |
|
1546
CALL
Medtronic
MDT
$117B
| $3.8M | 0.01% |
48,900
-90,200
| -65% | -$7.49M |
|
1547
CALL
United Airlines
UAL
$38.5B
| $3.79M | 0.01% |
62,300
-36,200
| -37% | -$2.41M |
|
1548
PUT
Littelfuse
LFUS
$10.4B
| $3.78M | 0.01% |
+19,300
| New | +$3.5M |
|
|
CMA
1549
CALL
DELISTED
Comerica
CMA
| $3.77M | 0.01% |
49,400
-2,100
| -4% | -$150K |
|
1550
ZTO Express
ZTO
$16.1B
| $3.77M | 0.01% |
268,339
+244,908
| +1,045% | +$3.53M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.